- Home
- AVIR vs LTBR Comparison
AVIR vs LTBR Comparison
Compare AVIR & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- LTBR
- Stock Information
- Founded
- AVIR 2012
- LTBR 1992
- Country
- AVIR United States
- LTBR United States
- Employees
- AVIR N/A
- LTBR N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- LTBR Professional Services
- Sector
- AVIR Health Care
- LTBR Consumer Discretionary
- Exchange
- AVIR Nasdaq
- LTBR Nasdaq
- Market Cap
- AVIR 273.0M
- LTBR 326.6M
- IPO Year
- AVIR 2020
- LTBR N/A
- Fundamental
- Price
- AVIR $3.67
- LTBR $13.47
- Analyst Decision
- AVIR Hold
- LTBR
- Analyst Count
- AVIR 1
- LTBR 0
- Target Price
- AVIR $6.00
- LTBR N/A
- AVG Volume (30 Days)
- AVIR 410.2K
- LTBR 2.0M
- Earning Date
- AVIR 08-06-2025
- LTBR 07-30-2025
- Dividend Yield
- AVIR N/A
- LTBR N/A
- EPS Growth
- AVIR N/A
- LTBR N/A
- EPS
- AVIR N/A
- LTBR N/A
- Revenue
- AVIR N/A
- LTBR N/A
- Revenue This Year
- AVIR N/A
- LTBR N/A
- Revenue Next Year
- AVIR N/A
- LTBR N/A
- P/E Ratio
- AVIR N/A
- LTBR N/A
- Revenue Growth
- AVIR N/A
- LTBR N/A
- 52 Week Low
- AVIR $2.46
- LTBR $2.24
- 52 Week High
- AVIR $4.15
- LTBR $17.70
- Technical
- Relative Strength Index (RSI)
- AVIR 76.11
- LTBR 52.63
- Support Level
- AVIR $3.15
- LTBR $13.35
- Resistance Level
- AVIR $3.35
- LTBR $14.71
- Average True Range (ATR)
- AVIR 0.13
- LTBR 1.16
- MACD
- AVIR 0.03
- LTBR -0.20
- Stochastic Oscillator
- AVIR 83.81
- LTBR 36.96
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.